Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

Published:2013-01-09 Issue:1 Volume:31 Page:38-44
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:Cardiovasc Ther

Author:

Bourge Robert C.¹,Tapson Victor F.²,Safdar Zeenat³,Benza Raymond L.⁴,Channick Richard N.⁵,Rosenzweig Erika B.⁶,Shapiro Shelley⁷,White R. James⁸,McSwain Christopher Shane⁹,Gotzkowsky Stephen Karl⁹,Nelsen Andrew C.⁹,Rubin Lewis J.¹⁰

Affiliation:

1. University of Alabama at Birmingham Birmingham AL USA

2. Duke University Medical Center Durham NC USA

3. Baylor College of Medicine Houston TX USA

4. Allegheny General Hospital Pittsburgh PA USA

5. Massachusetts General Hospital Boston MA USA

6. Columbia Presbyterian Medical Center New York NY USA

7. David Geffen UCLA School of Medicine, Greater Los Angeles VA Healthcare System Los Angeles CA USA

8. University of Rochester Medical Center Rochester NY USA

9. United Therapeutics Corp. Research Triangle Park NC USA

10. UCSD Medical Center San Diego CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1755-5922.12008

Reference28 articles.

1. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

2. Prostanoid therapy for pulmonary arterial hypertension

3. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

4. Cellular and molecular pathobiology of pulmonary arterial hypertension

5. Treatment of Pulmonary Arterial Hypertension

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry;Pulmonary Pharmacology & Therapeutics;2023-10

2. Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension;Pulmonary Circulation;2023-01

3. Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension;Journal of Managed Care & Specialty Pharmacy;2023-01

4. Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension;Chest;2022-11

5. The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study;Frontiers in Pharmacology;2022-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3